ResMed | RMD - Assets

Stock Price
251.41
Daily Change
-3.33 -1.31%
Monthly
2.47%
Yearly
4.55%
Q1 Forecast
250.35

ResMed reported $8.5B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Ansell USD 3.32B 79.8M Jun/2025
AtriCure USD 635.44M 26.59M Sep/2025
Baxter International USD 21.07B 21M Sep/2025
Cochlear AUD 2.82B 38.9M Jun/2025
Cooper Companies USD 12.39B 18.1M Sep/2025
CSL USD 39.4B 957M Jun/2025
Dexcom USD 7.5B 173M Sep/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Fisher Paykel Healthcare NZD 2.63B 80.5M Dec/2025
Globus Medical USD 5.1B 134.55M Sep/2025
Haemonetics USD 2.44B 19.94M Sep/2025
Hologic USD 9.18B 165.8M Dec/2025
Idexx Laboratories USD 3.39B 55.92M Sep/2025
Insulet USD 3.03B 439.9M Sep/2025
Integra LifeSciences USD 3.65B 21.45M Sep/2025
Intuitive Surgical USD 20.46B 1.11B Dec/2025
Masimo USD 1.82B 585.1M Sep/2025
Medtronic USD 90.97B 708M Jun/2025
Philips EUR 26.34B 40M Sep/2025
Ramsay Health Care AUD 22.48B 1.82B Jun/2025
ResMed USD 8.5B 195.02M Dec/2025
Sigma Healthcare AUD 8.29B 6.91B Dec/2025
Sonic Healthcare AUD 15.38B 550.57M Dec/2024
Steris USD 10.41B 5.7M Sep/2025
Teleflex USD 7.87B 496.72M Sep/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025